Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
Update on antimicrobial susceptibility trends among Streptococcus pneumoniae in the United States: report of ceftaroline activity from the SENTRY Antimicrobial Surveillance Program (1998–2011)Jones, Ronald N ; Sader, Helio S ; Mendes, Rodrigo E ; Flamm, Robert KDiagnostic microbiology and infectious disease, 2013, Vol.75 (1), p.107-109 [Periódico revisado por pares]United States: Elsevier IncTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
Antimicrobial susceptibility patterns of community- and hospital-acquired methicillin-resistant Staphylococcus aureus from United States Hospitals: results from the AWARE Ceftaroline Surveillance Program (2012–2014)Sader, Helio S ; Mendes, Rodrigo E ; Jones, Ronald N ; Flamm, Robert KDiagnostic microbiology and infectious disease, 2016-09, Vol.86 (1), p.76-79 [Periódico revisado por pares]United States: Elsevier IncTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
Oritavancin in vitro activity against contemporary Staphylococcus aureus isolates responsible for invasive community- and healthcare-associated infections among patients in the United States (2013–2014)Duncan, Leonard R. ; Sader, Helio S. ; Flamm, Robert K. ; Jones, Ronald N. ; Mendes, Rodrigo E.Diagnostic microbiology and infectious disease, 2016-11, Vol.86 (3), p.303-306 [Periódico revisado por pares]United States: Elsevier IncTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
Doripenem activity tested against a global collection of Enterobacteriaceae, including isolates resistant to other extended-spectrum agentsMendes, Rodrigo E ; Rhomberg, Paul R ; Bell, Jan M ; Turnidge, John D ; Sader, Helio SDiagnostic microbiology and infectious disease, 2009-04, Vol.63 (4), p.415-425 [Periódico revisado por pares]New York, NY: Elsevier IncTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
Update on the in vitro activity of ceftaroline against Staphylococcus aureus from United States (US) medical centers stratified by infection type (2018−2020)Sader, Helio S. ; Castanheira, Mariana ; Duncan, Leonard R. ; Mendes, Rodrigo E.Diagnostic microbiology and infectious disease, 2023-01, Vol.105 (1), p.115820-115820, Article 115820 [Periódico revisado por pares]United States: Elsevier IncTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
Antimicrobial activity of dalbavancin and comparators against Staphylococcus aureus causing pneumonia in patients with and without cystic fibrosisSader, Helio S. ; Duncan, Leonard R. ; Mendes, Rodrigo E.International journal of infectious diseases, 2021-06, Vol.107, p.69-71 [Periódico revisado por pares]Canada: Elsevier LtdTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
Tigecycline activity tested against carbapenem-resistant Enterobacteriaceae from 18 European nations: results from the SENTRY surveillance program (2010–2013)Sader, Helio S ; Castanheira, Mariana ; Flamm, Robert K ; Mendes, Rodrigo E ; Farrell, David J ; Jones, Ronald NDiagnostic microbiology and infectious disease, 2015-10, Vol.83 (2), p.183-186 [Periódico revisado por pares]United States: Elsevier IncTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
In vitro activity of telavancin against Staphylococcus aureus causing pneumonia or skin and skin structure infections with concomitant bloodstream infections in United States hospitals (2012–2016)Duncan, Leonard R. ; Flamm, Robert K. ; Sader, Helio S. ; Mendes, Rodrigo E.Diagnostic microbiology and infectious disease, 2019-02, Vol.93 (2), p.167-170 [Periódico revisado por pares]United States: Elsevier IncTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
Antimicrobial activity of ceftaroline and comparator agents when tested against numerous species of coagulase-negative Staphylococcus causing infection in US hospitalsSader, Helio S ; Farrell, David J ; Flamm, Robert K ; Streit, Jennifer M ; Mendes, Rodrigo E ; Jones, Ronald NDiagnostic microbiology and infectious disease, 2016-05, Vol.85 (1), p.80-84 [Periódico revisado por pares]United States: Elsevier IncTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
Ceftazidime/avibactam tested against Gram-negative bacteria from intensive care unit (ICU) and non-ICU patients, including those with ventilator-associated pneumoniaSader, Helio S ; Castanheira, Mariana ; Flamm, Robert K ; Mendes, Rodrigo E ; Farrell, David J ; Jones, Ronald NInternational journal of antimicrobial agents, 2015-07, Vol.46 (1), p.53-59 [Periódico revisado por pares]Netherlands: Elsevier B.VTexto completo disponível |